• Best stocks to buy now
  • Contact
  • Disclaimer
Monday, February 6, 2023
No Result
View All Result
  • ItalianoItaliano
Best Stocks
  • News
  • Best stocks to buy nowHOT
  • Categories
    • Crypto
    • Dow Jones Today
    • Pre-IPO and Startups
    • Tech Stocks
    • Utility Stocks
  • Data & Tools
    • Indices
    • Portfolio Tracker
    • Stock Quotes
    • Stock Targets
  • About us
Best Stocks
Home News

Large decline in short interest is observed at Confluent, Inc. (NASDAQ:CFLT).

by Yasmim Mendonça
December 5, 2022
in News
MET stock news

Source: Getty Images

0
SHARES
80
VIEWS
Share on FacebookShare on Twitter

The short interest for Confluent, Inc. dramatically decreased in November (NASDAQ: CFLT). As of November 15, 12,920,000 shares were shorted, a 15.7% decrease from 15,320,000 shares on October 31. Based on an average daily volume of 2,510,000 shares, the days-to-cover ratio is 5.1 days. Currently, 9.0% of the stock is being sold short.

Confluent (NASDAQ: CFLT) published its most recent quarterly earnings report on November 2. The company’s earnings per share (EPS) for the quarter came in at $0.40, which was in line with analysts’ expectations. Confluent had a negative net margin of 85.73 percent and a negative return on equity of 55.60 percent. The company’s revenues for the quarter were $151.73 million, as opposed to the consensus estimate of $144.39 million. According to sell-side analysts, Confluent will earn a negative $1.62 profit per share for the current fiscal year.
Several research firms recently provided feedback to CFLT. In a research note, Davidson reduced Confluent’s price objective from $44.00 to $33.00 on November 3. Confluent’s price objective was reduced by Morgan Stanley from $38.00 to $35.00 in a research note released on November 3, and the stock was rated as “equal weight.” In a research note published on Tuesday, August 9, Cowen increased their $39.00 price objective on Confluent. On Friday, September 30, Confluence was mentioned in a report by Trust Financial. They recommended “buy” for the company with a $35.00 price goal. Not to mention, JPMorgan Chase & Co. decreased its price objective for Confluent from $30.00 to $25.00 and gave the company a “neutral” rating in a research report that was released on November 3. The company was rated as a buy by six research experts and a hold by another six. According to information from Bloomberg.com, Confluent currently has an average rating of “Moderate Buy” and a consensus target price of $35.36.

At noon on Friday, the price of CFLT shares had risen $0.09 to $22.62.

One million six hundred eleven thousand two hundred eighty-seven shares were traded in contrast to the company’s normal volume of 3,054,205 shares. Confluent’s 52-week high and low are $81.11 and $16.48, respectively. The company’s respective quick, current, and debt-to-equity ratios are 5.74, 5.74, and 1.38. The company’s 50- and 200-day moving averages are $23.55 and $24.53, respectively. The company’s market value is $6.48 billion, its P/E ratio is -13.54, and its beta is 1.06.

SVP Chad Verbowski additionally sold 9,441 shares of company stock on November 22. The stock was sold at an average price of $20.11 for a total transaction value of $189,858.51. After completing the transaction, the senior vice president now owns 338,391 company shares, valued at $6,805,043.01. You can examine the document that describes the transaction on the Securities and Exchange Commission (SEC) website. Steffan Tomlinson, the CFO, sold 15,393 company stock on November 11. Averaging $25 per share, the stock was sold for $384,825.00. Following the sale, the chief financial officer now owns 106,407 company shares worth $2,660,175; You can examine the document that describes the transaction on the Securities and Exchange Commission (SEC) website. SVP Chad Verbowski concluded a deal involving the sale of 9,441 shares of company stock on November 22. The stock was sold at an average price of $20.11 for a total transaction value of $189,858.51. The senior vice president acquired a total of 338,391 shares of the company, worth a total of $6,805,043.01. The disclosure for this sale is available here. Insiders generated sales of $13,041,645 through the sale of 571,702 shares of company stock during the preceding quarter. Currently, insiders own 27.94% of the stock.

A few institutional investors and hedge funds have recently changed the number of shares they own. During the third quarter, Vanguard Group Inc. grew its holdings in Confluent shares by 15.6%. Vanguard Group Inc. now owns 10,877,130 shares, valued at $258,549,000, after acquiring an additional 1,470,650 shares over the last 12 months. BlackRock Inc. grew its stake in Confluent shares by 1.0% during the third quarter. BlackRock Inc. added 78,339 shares during that period, bringing its total share count to 8,189,217, for a total market value of $194,656,000. JPMorgan Chase & Co. grew its stake in Confluent shares by 43.0% during the first quarter. JPMorgan Chase & Co. now owns 7,971,525 shares worth $326,833,000, after acquiring an additional 2,398,212 shares throughout the last period. Durable Capital Partners LP grew its holdings in Confluent shares by 6.8% during the first quarter. Durable Capital Partners LP now owns 465,214 more company shares than it did at the beginning of the quarter, for a total market value of $300,496,000. Finally, Altimeter Capital Management LP boosted its stake in Confluent by 79.9% during the first quarter. Altimeter Capital Management LP now owns 5,306,700 shares of the company’s stock valued at $217,575,000 after acquiring an additional 2,356,700 shares. Hedge funds and institutional investors now own 40.65% of the stock.

Tags: CFLT, Analyst Rating
Yasmim Mendonça

Yasmim Mendonça

Yasmine's focus is on uncovering early-stage ideas with the potential to have a lasting impact. Her educational background includes a bachelor's degree in finance, an MBA, and two tests completed - the CFA and CMT.

DISCLAIMER

Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.

The Best Stocks, its managers, its employees, affiliates and assigns (collectively “The Company”) do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above.

READ MORE

Follow us on Social Media
Facebook – YouTube – Twitter

Write for us
Finance – Business

Best-Stocks-Logo_dark

Categories
Best Stocks to buy now
Crypto
Dow Jones Today
Pre-IPO and Startups
Tech stocks
Utility Stocks

Data and Tools
Quote
Target
Wealth
Converter
Dow Jones Today

Best Stocks to Buy Now

We are a financial media dedicated to providing stock recommendations, news, and real-time stock prices.

  • Disclaimer
  • Privacy Policy
  • Best stocks to buy now
  • Contact
  • Write for us – Finance, Crypto

© 2023 Best Stocks

No Result
View All Result
  • Home
  • News
  • Best stocks to buy now
  • Categories
    • Crypto
    • Dow Jones Today
    • Pre-IPO and Startups
    • Tech stocks
    • Utility Stocks
  • Data & Tools
    • Indices
    • Portfolio Tracker
    • Stock Quotes
    • Stock Targets
  • About us
  • English
  • Italiano

© 2023 Best Stocks